Kura Oncology, Inc. (KURA)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

19 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue$67.5M$53.9M$0
Research & development$251.1M$170.0M$115.2M$92.8M$84.7M$60.4M$47.8M$46.8M$26.4M
Operating expenses$371.1M$247.1M$165.8M$139.9M$131.3M$91.9M$67.5M$62.9M$36.1M$28.4M$23.9M
Operating income−$303.6M−$193.2M−$165.8M−$139.9M−$23,907−$22,734−$22,341−$23,440−$20,509
Net income−$278.7M−$174.0M−$152.6M−$135.8M−$130.5M−$89.6M−$63.1M−$60.4M−$35.4M−$27.6M−$22.6M−$30,734−$28,611−$27,315−$27,040−$22,395−$19,996−$33,623−$14,977
Basic EPSper diluted share-$3.18-$2.02-$2.08-$2.03-$1.97-$1.69-$1.51-$1.72-$1.52-$1.47-$2.28-$0.01-$0.01-$0.01-$0.01$0.00
Diluted EPSper diluted share-$3.18-$2.02-$2.08-$2.03-$1.97-$1.69-$1.51-$1.72-$1.52-$1.47-$2.28-$0.01-$0.01-$0.01-$0.01$0.00

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys3$713.2K disclosed value
Sells (SEC code S)52$3.22M disclosed value
55 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 18, 2026Form 4 · 10b5-1Leoni MollieChief Medical OfficerSellCommon Stock84.9K$9.82$834.0K182.3K
May 21, 2026Form 4 · 10b5-1Powl Brian T.Chief Commercial OfficerSellCommon Stock10.0K$11.00$110.0K173.6K
May 19, 2026Form 4 · 10b5-1FORD KATHLEENChief Operating OfficerSellCommon Stock2.3K$9.08$20.5K153.6K
May 19, 2026Form 4 · 10b5-1Powl Brian T.Chief Commercial OfficerSellCommon Stock339$9.21$3.1K183.6K
May 18, 2026Form 4 · 10b5-1Bair Teresa BrophyChief Legal OfficerSellCommon Stock2.3K$9.38$21.2K226.9K